Intellectual Property India Publishes Patent Application for 'Compositions Comprising A Bispecific Gprc5d/Cd3 Antibody' Filed by Janssen Biotech, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517090844 A) filed by Janssen Biotech, Inc., Horsham, U.S.A., on Sept. 23, for 'compositions comprising a bispecific gprc5d/cd3 antibody.'

Inventor(s) include Vargo, Kevin B.; Heinaman, Daniel P; Javiya, Curie K.; and Muzammil, Salman.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are aqueous pharmaceutical compositions comprising formulations of a bispecific GPRC5D/CD3 antibody or an antigen-binding fragment thereof and methods of preparing the same. Also provided herein are methods of treating cancer in a subject in need t...